Safety and feasibility of third-party multipotent adult progenitor cells for immunomodulation therapy after liver transplantation--a phase I study (MISOT-I)Felix Popp, Marc H. Dahlke, Johannes Dillmann et al.|Journal of Translational Medicine|2011Cited by 51
Third-Party Multipotent Adult Progenitor Cells as a Novel Cell Therapy in Solid Organ TransplantationElke Eggenhofer, Marc-Hendrik Dahlke, Wouter Van’t Hof et al.|Transplantation|2012Cited by 0